Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27411382)

Published in Diabetes on July 13, 2016

Authors

Shyam Sundar Nandi1, Hong Zheng1, Neeru M Sharma1, Hamid R Shahshahan1, Kaushik P Patel1, Paras K Mishra2

Author Affiliations

1: Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE.
2: Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE paraskumar.mishra@unmc.edu.

Associated clinical trials:

A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971

Articles cited by this

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53

MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04

Characterization of microRNA expression profiles in normal human tissues. BMC Genomics (2007) 8.01

Diabetic cardiomyopathy revisited. Circulation (2007) 6.76

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev (2008) 5.39

New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol (1972) 4.86

Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature (2014) 3.31

Developing microRNA therapeutics. Circ Res (2012) 2.58

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation (1986) 2.38

Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev (1999) 2.38

A simple array platform for microRNA analysis and its application in mouse tissues. RNA (2007) 1.91

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. J Clin Invest (2012) 1.90

Diabetes mellitus, a microRNA-related disease? Transl Res (2011) 1.82

MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med (2009) 1.67

Non-coding RNAs in cardiac remodeling and heart failure. Circ Res (2013) 1.66

The beta-adrenergic receptors. Herz (2002) 1.48

miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev (2010) 1.44

MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem Biophys Res Commun (2009) 1.31

Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr (2007) 1.21

Enhanced replication of simian immunodeficiency virus adjacent to catecholaminergic varicosities in primate lymph nodes. J Virol (2006) 1.18

Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes (2004) 1.17

MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade. Circ Res (2014) 1.12

IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J Cell Mol Med (2012) 1.08

Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes (2013) 1.05

Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation (1993) 1.05

Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02

Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02

Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension (1998) 1.00

Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med (2014) 1.00

Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts. Cell Biochem Biophys (2014) 0.98

Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Its role in the depletion of cardiac norepinephrine stores. Circ Res (1967) 0.93

Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations. Protein Cell (2010) 0.86

Regulation of SERCA pumps expression in diabetes. Cell Calcium (2014) 0.85

Decreased expression of beta1- and beta2-adrenoceptors in human diabetic atrial appendage. Cardiovasc Diabetol (2003) 0.85

Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium. Diabetes (1983) 0.85

Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractility. Eur J Heart Fail (2015) 0.83

Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading. Am J Transl Res (2015) 0.83

Impaired catecholamine secretion as a cause of diabetic autonomic neuropathy. Diabetes Res Clin Pract (1988) 0.81

Myocardial catecholamines and the pathophysiology of heart failure. Circulation (1990) 0.80

Streptozotocin-induced diabetes in rats causes neuronal deficits in tyrosine hydroxylase and 5-hydroxytryptamine specific to mesenteric perivascular sympathetic nerves and without loss of nerve fibers. Exp Neurol (1991) 0.79

The glucose effect in rat liver: studies of delta-aminolevulinate synthase and tyrosine aminotransferase. Biochim Biophys Acta (1973) 0.79

Biventricular pacing cardiac contractility modulation improves cardiac contractile function via upregulating SERCA2 and miR-133 in a rabbit model of congestive heart failure. Cell Physiol Biochem (2014) 0.79

Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure. J Cardiol (2011) 0.78

A novel quantitative method for diabetic cardiac autonomic neuropathy assessment in type 1 diabetic mice. J Diabetes Sci Technol (2014) 0.78

Hydrocortisone regulation and expression of tyrosine aminotransferase gene in various tissues of rat. Biomed Biochim Acta (1990) 0.78

Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging. Am J Nucl Med Mol Imaging (2012) 0.78

[Tissue-specific hormonal regulation of the level of tyrosine aminotransferase mRNA in rats]. Biokhimiia (1990) 0.76